Novartis AG (NVS) Stock Forecast & Price Target

NVS price $155.94 -0.93 -0.59%

Ticker
NVS
Price
$155.94
Change
-0.93 -0.59%
Market cap ?
$296.39B
Sector
Healthcare
Industry
Drug Manufacturers - General

Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. The company was founded on February 29, 1996 and is…

Fair value

NVS fair value $217.21. Price $155.94. Price is 28% below fair value.

Below fair value, around its usual discount.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 15.82B. Growth 8.32%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 1.90B. Net debt 25.60B. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Compare NVS

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2027-02-03—2.23—14.69B
2026-10-272.462.2514.52B14.53B
2026-07-212.412.1714.41B14.07B
2026-04-281.992.1113.11B13.44B
2026-02-042.031.9913.34B13.70B
2025-10-282.252.2614.36B13.64B
2025-07-172.422.3814.28B13.94B
2025-04-292.282.1213.62B13.90B
2025-01-311.981.8013.56B12.84B
2024-10-292.061.9413.17B12.76B
2024-07-181.971.8912.51B12.54B
2024-04-231.801.7311.83B11.44B
2024-01-311.531.6411.78B11.88B
2023-10-241.741.7012.09B12.42B
2023-07-181.831.6813.94B13.47B
2023-04-251.711.5513.21B12.72B
2023-02-011.511.4213.09B13.22B
2022-10-251.581.5712.84B12.88B
2022-07-191.561.5113.09B12.88B
2022-04-261.461.4412.81B12.62B
2022-02-021.401.4413.52B13.33B
2021-10-261.711.6513.37B12.95B
2021-07-211.661.5313.29B12.95B
2021-04-271.521.5712.69B13.25B
2021-01-261.341.3813.03B13.22B
2020-10-271.521.4212.54B11.93B
2020-07-211.351.2911.62B11.18B
2020-04-281.551.3712.71B10.95B
2020-01-291.311.3212.72B12.42B
2019-10-221.411.3112.48B12.02B
2019-07-181.321.2012.02B10.84B
2019-04-241.201.1111.46B10.96B
2019-01-301.241.3313.66B13.98B
2018-10-181.311.3111.39B11.21B
2018-07-181.261.2713.45B13.24B
2018-04-191.281.2512.93B12.93B
2018-01-241.201.1613.16B12.94B
2017-10-241.291.2512.69B12.29B
2017-07-181.211.1612.49B12.28B
2017-04-251.131.1011.79B11.57B

Dividends

Yield 3.04%. Payout ratio 67.77%. Frequency Annual.

Safety score 82/100 · Safe. Payout ratio is 68% of earnings. Dividends use a moderate share of free cash flow. Dividends were paid in 30 separate years. Yield is 3.0%, in a range that is usually sustainable.

Ex-dateDividendRecordPaymentFrequency
2026-03-11$4.742026-03-112026-03-16Annual
2025-03-12$3.992025-03-122025-04-25Annual
2024-03-07$3.202024-03-082024-04-19Annual
2023-03-09$3.502023-03-102023-03-20Annual
2022-03-08$3.332022-03-092022-03-17Annual
2021-03-04$3.202021-03-052021-03-15Annual
2020-03-03$3.092020-03-042020-03-12Annual
2019-03-04$2.572019-03-052019-03-13Annual
2018-03-06$2.672018-03-072018-04-25Annual
2017-03-01$2.462017-03-032017-04-20Annual
2016-02-24$2.472016-02-262016-04-15Annual
2015-03-02$2.522015-03-042015-04-20Annual
2014-02-27$2.442014-03-032014-04-10Annual
2013-02-26$2.272013-02-282013-04-05Annual
2012-02-27$2.202012-02-292012-04-05Annual
2011-02-24$2.112011-02-282011-04-08Annual
2010-03-02$1.782010-03-042010-04-13Annual
2009-02-24$1.542009-02-262009-04-06Annual
2008-02-26$1.322008-02-282008-04-11Annual
2007-03-06$0.972007-03-082007-04-10Annual
2006-02-28$0.802006-03-022006-04-03Annual
2005-03-01$0.862005-03-032005-04-06Annual
2004-02-24$0.722004-02-262004-03-30Annual
2003-03-04$0.632003-03-062003-04-07Annual
2002-03-21$0.472002-03-252002-04-22Annual
2001-03-22$0.452001-03-262001-04-20Annual
2000-11-14$0.97——Semi-Annual
2000-04-12$0.402000-04-142000-05-11Annual
1999-04-21$0.481999-04-231999-05-24Annual
1998-04-21$0.421998-04-231998-05-19Annual
1997-04-16$0.341997-04-181997-05-15Annual
1997-02-26$1.531997-02-251997-03-19Irregular

Insider trades

DateInsiderActionSharesPriceValue
No data yet.

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 1.68K, holders +34 vs prior quarter. Ownership 7.15%.

HolderSharesChangeChange %Value
FISHER ASSET MANAGEMENT, LLC15.52M1.64M+11.79%2.43B
MORGAN STANLEY8.73M199.79K+2.34%1.37B
DIMENSIONAL FUND ADVISORS LP8.12M7.47K+0.09%1.27B
PRIMECAP MANAGEMENT CO/CA/6.59M-975.23K-12.89%1.03B
LOOMIS SAYLES & CO L P5.24M-186.79K-3.44%821.10M
BANK OF AMERICA CORP /DE/4.91M-52.86K-1.07%769.49M
FRANKLIN TEMPLETON INC3.25M-158.66K-4.65%509.54M
BLACKROCK, INC.3.05M98.23K+3.33%477.68M
GOLDMAN SACHS GROUP INC2.98M-3.55M-54.33%467.05M
NORTHERN TRUST CORP2.79M6.52K+0.23%437.68M
NATIXIS ADVISORS, LLC2.39M150.37K+6.72%374.02M
ENVESTNET ASSET MANAGEMENT INC2.33M19.59K+0.85%365.31M
JPMORGAN CHASE & CO2.26M459.77K+25.48%356.85M
JUPITER TOPCO LLC2.22M2.22MNew348.13M
GQG PARTNERS LLC2.15M-296.14K-12.10%337.13M
LMR PARTNERS LLP2.13M828.70K+63.56%334.21M
FMR LLC2.06M364.41K+21.52%322.44M
CULLEN CAPITAL MANAGEMENT, LLC2.03M-4.92K-0.24%318.62M
JONES FINANCIAL COMPANIES LLLP1.97M152.25K+8.36%306.81M
WCM INVESTMENT MANAGEMENT, LLC1.90M441.17K+30.15%300.11M
WELLS FARGO & COMPANY/MN1.83M-66.86K-3.53%286.61M
RAYMOND JAMES FINANCIAL INC1.80M-130.54K-6.76%282.31M
PRINCIPAL FINANCIAL GROUP INC1.57M33.01K+2.15%245.39M
UBS GROUP AG1.18M-608.73K-33.95%185.62M
HOLOCENE ADVISORS, LP1.04M1.04MNew162.57M

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

The Novartis AG (NVS) forecast collects the published price target, analyst ratings, and earnings estimates when they are available.

Forecasts are third-party estimates and often wrong. They are not investment advice.

NVS price target

A low, average, and high target are shown in the tool when analysts have published them.

Is Novartis AG a buy or sell?

A Buy, Hold, and Sell split is shown when analysts have published ratings. It is not a recommendation.

Novartis AG earnings and revenue forecast

EPS and revenue estimates for the coming years are drawn in the chart when analysts have published them.

NVS score and fair value

The Stocklytics Score, when it is published for NVS, averages value, quality, and growth on a 0–100 scale. It is not a price target. Fair value is a separate estimate on the fair value tab.

NVS forecast FAQs

What is the NVS price target?

A 12-month average target is shown on this page when analysts have published one.

Is Novartis AG a buy or sell?

A consensus is shown when analysts have published ratings. It is not a recommendation.

What is the Novartis AG stock forecast for 2026?

An EPS estimate for 2026 is shown in the chart on this page when analysts have published one.

What will NVS be worth in 2030?

No reliable forecast exists that far out.

When is Novartis AG's next earnings report?

The next earnings date is shown on the stock page when a future report is on the calendar. This forecast does not invent a date.

Capital is at risk. Stocklytics is operated by Stocklytics Inc., a Marshall Islands company. It is not regulated by the FCA and does not give investment advice.

Novartis AG (NVS) Stock Forecast & Price Target

NVS$155.94-0.93 -0.59%

$296.39B

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History